Updated:
SC Laboratories
Jeff Gray co-founded SC Laboratories in 2010, building the largest multi-state cannabis and hemp testing platform in the US, processing over 740,000 tests.
SC Laboratories
Cannabis and hemp testing and analysis you can use to build your reputation and grow your business.
General information
Firm type
other
Year founded
2010
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Santa Cruz
Corporate office
Santa Cruz, CA, United States
Additional offices
Arizona · Oregon · Colorado · Michigan
Principals
Jeff Gray
Chief Executive Officer
Alec Dixon
Executive VP, Client Relations
Ryan DeCurtis
Senior VP, Technology
Sector focus
Frequently asked questions
Who runs investment and strategic decisions at SC Laboratories?
Jeff Gray serves as CEO, Alec Dixon is Executive VP of Client Relations, and Ryan DeCurtis is Senior VP of Technology. The three co-founders — Gray, Dixon, and Josh Wurzer (Chief Operating Officer) — have shaped the firm's direction since 2010. The company also maintains a board of advisors including Shaun Kelley, Amy McDonald, Mike Branvold, and Hirsh Jain.
How does SC Laboratories source business outside its home state of California?
SC Laboratories operates cannabis testing facilities in Arizona, Oregon, Colorado, and Michigan, and runs a national hemp testing panel registered in Idaho, Illinois, New Mexico, New York, and Texas. Multi-state cannabis operators contract with SC Labs across these jurisdictions, while hemp clients can ship samples to the national panel regardless of their home state. The firm's R&D Center of Excellence in Santa Cruz supports all locations.
Is SC Laboratories a pure-play testing lab, or does it have exposure to cannabis plant-touching operations?
SC Laboratories is a pure-play testing lab. It does not cultivate, manufacture, distribute, or sell cannabis or hemp products. Its sole revenue source is laboratory testing fees, which structurally insulates it from conflicts that could arise if it were vertically integrated with operators whose products it tests.
What testing services does SC Laboratories provide?
The lab performs potency analysis, terpene profiling, pesticide screening, heavy metals testing, residual solvents analysis, and microbiological contamination detection. Its chemometric terpene reporting categorizes strains by chemical profile rather than the traditional indica/sativa/hybrid taxonomy, a shift the firm has advocated publicly since at least 2023. On the hemp side, it also tests for Delta-8 THC adulterants and synthesis byproducts.
Does SC Laboratories have a known philanthropic or corporate venture arm?
No philanthropic foundation, corporate venture arm, or adjacent investment vehicle has been publicly disclosed. The firm's public footprint is limited to its operating labs, content marketing through its blog, and advocacy work by its principals on terpene categorization and federal hemp testing standards.
What is SC Laboratories' known posture on co-investments or partnerships with external entities?
SC Laboratories has not disclosed any co-investment vehicles, partnership funds, or external investment positions. It presents itself as an independent operating company serving growers, extractors, product makers, and retailers. Its board of advisors includes individuals from outside the firm, but the nature of their engagement has not been characterized as investment-related.
How does SC Laboratories compare to other multi-state cannabis testing labs?
SC Laboratories claims to be the largest multi-state cannabis testing lab by facility count and geographic reach, with active cannabis labs in five states and registered hemp testing in five additional states. Its chemometric terpene reporting system and a stated data set of over 740,000 tests differentiate it from labs that report only potency and safety metrics. The firm's public advocacy for retiring the indica/sativa classification and for federal hemp testing harmonization adds an industry-standard-setting dimension not commonly seen among regional competitors.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: